Skip to content
Peptigraph home

Cagrilintide Side Effects: What Studies and Users Report

What FDA labels, clinical studies and people who use Cagrilintide report, how strong that evidence is, and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureAmylin analogUpdated

Side effects reported in studies

Side effects reported in published studies, strongest design first. Frequencies are quoted as the source gives them; animal results are labelled.

Side effects of Cagrilintide in labels and published studies
Side effectHow commonStudy typeSource
Nausea4 of 30 on cagrilintide 2.4 mg alone; 9 of 31 on cagrilintide plus semaglutide; 5 of 31 on semaglutide aloneHuman RCTn = 92ClinicalTrials.gov NCT04982575
Constipation4 of 30 on cagrilintide 2.4 mg alone; 5 of 31 on cagrilintide plus semaglutide; 4 of 31 on semaglutide aloneHuman RCTn = 92ClinicalTrials.gov NCT04982575
Headache3 of 30 on cagrilintide 2.4 mg alone; 0 of 31 on cagrilintide plus semaglutide; 3 of 31 on semaglutide aloneHuman RCTn = 92ClinicalTrials.gov NCT04982575
Diarrhoea2 of 30 on cagrilintide 2.4 mg alone; 5 of 31 on cagrilintide plus semaglutide; 2 of 31 on semaglutide aloneHuman RCTn = 92ClinicalTrials.gov NCT04982575
Injection site reaction2 of 30 on cagrilintide 2.4 mg alone; 1 of 31 on cagrilintide plus semaglutide; 0 of 31 on semaglutide aloneHuman RCTn = 92ClinicalTrials.gov NCT04982575
Gastrointestinal adverse eventsmost common (mild or moderate); adverse events in 24 (80%) of the cagrilintide groupHuman RCTn = 92Lancet 2023, PMID 37364590
Gastrointestinal events and nausea41%-63% vs 32% with placebo; nausea 20%-47% vs 18%Human RCTLancet 2021, PMID 34798060
Nausea20 of 101 on cagrilintide 0.3 mg; 27 of 100 on cagrilintide 0.6 mg; 37 of 102 on cagrilintide 1.2 mg; 32 of 102 on cagrilintide 2.4 mg; 47 of 101 on cagrilintide 4.5 mg; 39 of 99 on liraglutide 3.0 mg; 18 of 101 on placeboHuman RCTClinicalTrials.gov NCT03856047
Vomiting6 of 101 on cagrilintide 0.3 mg; 6 of 100 on cagrilintide 0.6 mg; 5 of 102 on cagrilintide 1.2 mg; 9 of 102 on cagrilintide 2.4 mg; 8 of 101 on cagrilintide 4.5 mg; 20 of 99 on liraglutide 3.0 mg; 3 of 101 on placeboHuman RCTClinicalTrials.gov NCT03856047
Constipation11 of 101 on cagrilintide 0.3 mg; 9 of 100 on cagrilintide 0.6 mg; 8 of 102 on cagrilintide 1.2 mg; 17 of 102 on cagrilintide 2.4 mg; 21 of 101 on cagrilintide 4.5 mg; 26 of 99 on liraglutide 3.0 mg; 7 of 101 on placeboHuman RCTClinicalTrials.gov NCT03856047
Diarrhoea15 of 101 on cagrilintide 0.3 mg; 10 of 100 on cagrilintide 0.6 mg; 8 of 102 on cagrilintide 1.2 mg; 18 of 102 on cagrilintide 2.4 mg; 7 of 101 on cagrilintide 4.5 mg; 18 of 99 on liraglutide 3.0 mg; 9 of 101 on placeboHuman RCTClinicalTrials.gov NCT03856047
Injection site reaction4 of 101 on cagrilintide 0.3 mg; 4 of 100 on cagrilintide 0.6 mg; 7 of 102 on cagrilintide 1.2 mg; 12 of 102 on cagrilintide 2.4 mg; 10 of 101 on cagrilintide 4.5 mg; 1 of 99 on liraglutide 3.0 mg; 0 of 101 on placeboHuman RCTClinicalTrials.gov NCT03856047
Decreased appetite4 of 101 on cagrilintide 0.3 mg; 9 of 100 on cagrilintide 0.6 mg; 8 of 102 on cagrilintide 1.2 mg; 13 of 102 on cagrilintide 2.4 mg; 17 of 101 on cagrilintide 4.5 mg; 9 of 99 on liraglutide 3.0 mg; 4 of 101 on placeboHuman RCTClinicalTrials.gov NCT03856047
Dyspepsia3 of 101 on cagrilintide 0.3 mg; 2 of 100 on cagrilintide 0.6 mg; 3 of 102 on cagrilintide 1.2 mg; 3 of 102 on cagrilintide 2.4 mg; 4 of 101 on cagrilintide 4.5 mg; 10 of 99 on liraglutide 3.0 mg; 4 of 101 on placeboHuman RCTClinicalTrials.gov NCT03856047
Headache10 of 101 on cagrilintide 0.3 mg; 5 of 100 on cagrilintide 0.6 mg; 11 of 102 on cagrilintide 1.2 mg; 11 of 102 on cagrilintide 2.4 mg; 7 of 101 on cagrilintide 4.5 mg; 13 of 99 on liraglutide 3.0 mg; 12 of 101 on placeboHuman RCTClinicalTrials.gov NCT03856047
Dizziness8 of 101 on cagrilintide 0.3 mg; 2 of 100 on cagrilintide 0.6 mg; 8 of 102 on cagrilintide 1.2 mg; 9 of 102 on cagrilintide 2.4 mg; 9 of 101 on cagrilintide 4.5 mg; 5 of 99 on liraglutide 3.0 mg; 3 of 101 on placeboHuman RCTClinicalTrials.gov NCT03856047
Fatigue8 of 101 on cagrilintide 0.3 mg; 5 of 100 on cagrilintide 0.6 mg; 8 of 102 on cagrilintide 1.2 mg; 10 of 102 on cagrilintide 2.4 mg; 20 of 101 on cagrilintide 4.5 mg; 8 of 99 on liraglutide 3.0 mg; 3 of 101 on placeboHuman RCTClinicalTrials.gov NCT03856047
Administration-site reactionsamong the most frequent adverse events (no figure in abstract)Human RCTLancet 2021, PMID 34798060
Adverse events leading to discontinuation30 participants (4%)Human RCTLancet 2021, PMID 34798060
Adverse events (combined with semaglutide)“Most adverse events were mild to moderate in severity and the proportion of participants with one or more adverse event was similar across treatment groups.”Frequency not statedHuman RCTn = 96Lancet 2021, PMID 33894838
Gastrointestinal disorders (with semaglutide 2.4 mg)207 of 566 adverse events (37%)Human RCTn = 96Lancet 2021, PMID 33894838

Overall safety findings

What studies said about safety as a whole, without naming a specific effect.

Overall safety findings for Cagrilintide in published studies
FindingHow commonStudy typeSource
No serious adverse events in impairment studies“In both studies, no serious TEAEs, TEAEs leading to study withdrawal or deaths were reported.”Frequency not statedHuman controlled trialClinical pharmacokinetics 2026, PMID 42228334

What users report

Anecdotal evidence, 0 of 4

Side effects people describe from their own use of Cagrilintide, quoted from 46 Reddit threads we read in r/Peptides and r/Retatrutide (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.

Side effects people report from using Cagrilintide
What people noticedPeople reporting itIn their words
Tiredness or lethargy28“My first injection I was extremely tired. I’ve never experienced that with tirz.” r/Peptides, Sep 2024“I found cagri absolutely exhausting. I haven’t found tirz or Reta to be that way.” r/Retatrutide, Oct 2025
Nausea10“Cagri 0.25mg gave me instant nausea but only for the first 2h.” r/Peptides, Jul 2026“Cagri starting dose is .25mg, even that made me nausea.” r/Retatrutide, Feb 2025
Low mood or emotional flatness7“At first it made me feel emotionally flatlined and borderline depressed” r/Retatrutide, Dec 2025“Also gave me anhendonia” r/Retatrutide, Feb 2025
Constipation6“I have never been prone to constipation, even with SEMA but happened w Cagri so badly that I will never take it again.” r/Peptides, Nov 2024“it constipated me so bad, it scared me.” r/Retatrutide, Jun 2025
Vomiting4“swallowing my omegas made me puke” r/Peptides, Jul 2026“Anything I managed to get down instantly came back up.” r/Peptides, Jul 2026Also taking other compounds
Headache3“i get a headache the following day. For the whole day.” r/Peptides, Aug 2024Also taking other compounds“a headache sometimes on the day of shot” r/Peptides, Sep 2024Also taking other compounds
Muscle or joint aches2“I got muscle aches and lost all of my appetite.” r/Retatrutide, Feb 2025“severe fatigue and muscle aches.” r/Retatrutide, Feb 2026Also taking other compounds
Bloating or stomach heaviness2“Cagri makes me feel full, almost bloated sometimes” r/Peptides, Sep 2024Also taking other compounds“It felt like my stomach was frozen with rocks in it.” r/Peptides, Sep 2024Also taking other compounds
Feeling cold1“I was so COLD.” r/Retatrutide, Feb 2025Also taking other compounds
Vivid dreams1“I had such vivid dreams that I was not resting” r/Retatrutide, Feb 2025Also taking other compounds
Trouble sleeping1“I added cag tuesday and I’m back up at 3am” r/Peptides, Oct 2025Also taking other compounds
Low libido1“Killed my sex drive.” r/Peptides, Aug 2024
Lower back pain1“really intense low back pain for the first 2 days” r/Retatrutide, Sep 2024Also taking other compounds

5 people in the same threads said they noticed no side effects:

“But I didn’t have any side effects at all.” r/Retatrutide, Jan 2025Also taking other compounds“I did not have side effects” r/Retatrutide, Jan 2025Also taking other compounds

A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.

What is not known

  • How common each effect is at the doses people use outside of studies.
  • Effects that take longer to appear than the length of the published studies.
  • How Cagrilintide interacts with other medicines and supplements.
  • Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.

When to get medical help

Get urgent care for: trouble breathing, swelling of the face or throat, a widespread rash, severe or lasting stomach pain, fainting, or an injection site that becomes hot, red and spreading.

This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.

The phase 2 dose-finding trial

Permanent stops were similar across groups and mostly due to adverse events.[2]

Gastrointestinal events, especially nausea, were more common than on placebo across the tested range.[2]

Excess over placebo in percentage points across the cagrilintide dose range: gastrointestinal events 9 to 31, nausea 2 to 29.

Calculated from gi 41, 63; gi placebo 32; nausea 20, 47; nausea placebo 18. Formula: range ends minus placebo %

Administration-site reactions are named alongside stomach complaints.[2]

Heart rhythm, kidney and liver impairment, and the semaglutide combination

A thorough QT study reported that cagrilintide did not result in clinically relevant QTcF prolongation.[19]

In studies in renal and hepatic impairment, no serious treatment-emergent adverse events, withdrawals from adverse events, or deaths were reported.[1]

When added to semaglutide, most adverse events were mild to moderate and similar across arms.[3]

Common questions

What are the side effects of cagrilintide?

Gastrointestinal events, mostly nausea, and administration-site reactions were the most frequent in the dose-finding trial.[2]

What side effects do people who use Cagrilintide report?

In the 46 Reddit threads we read (11 Oct 2026), people most often described tiredness or lethargy (28 people), nausea (10 people), low mood or emotional flatness (7 people). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.

Is cagrilintide safe?

Early trials describe it as well tolerated, and a QT study found no relevant effect. It has no approved label of its own in the cached sources.[2]

Is Cagrilintide banned in sport?

Yes. Prohibited by WADA (S0). Tested athletes should not use it.

Does cagrilintide cause nausea?

Yes, more than placebo in the phase 2 trial. Nausea was 20% to 47% across doses versus 18% on placebo.[2]

More on Cagrilintide

Sources

  1. 1Renal or Hepatic Impairment Does Not Affect Pharmacokinetics, Safety, or Tolerability of Subcutaneous Cagrilintide.Clinical pharmacokinetics · 2026PMID 42228334Accessed 2 Oct 2026
  2. 2Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.Lancet (London, England) · 2021PMID 34798060Accessed 2 Oct 2026
  3. 3Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.Lancet (London, England) · 2021PMID 33894838Accessed 2 Oct 2026
  4. 4Efficacy and Safety of Co-administration of Cagrilintide s.c. 2.4 mg and Semaglutide s.c. 2.4 mg Once Weekly in Subjects With Type 2 DiabetesClinicalTrials.gov (U.S. National Library of Medicine) · 2021clinicaltrials.govAccessed 2 Oct 2026
  5. 5Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial.Lancet (London, England) · 2023PMID 37364590Accessed 11 Oct 2026
  6. 6Investigation of Safety and Efficacy of NNC0174-0833 for Weight Management - a Dose Finding Trial.ClinicalTrials.gov (U.S. National Library of Medicine) · 2019clinicaltrials.govAccessed 2 Oct 2026
  7. 7Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
  8. 8Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
  9. 9Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  10. 10Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
  11. 11Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
  12. 12Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
  13. 13Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
  14. 14Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  15. 15Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  16. 16Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
  17. 17Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
  18. 18Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
  19. 19Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.Diabetes, obesity & metabolism · 2024PMID 39279639Accessed 2 Oct 2026

Found an error? Report a correction.